Ethanol regulation of signaling: from cells to behavior

乙醇对信号传导的调节:从细胞到行为

基本信息

  • 批准号:
    7434535
  • 负责人:
  • 金额:
    $ 49.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-01 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Nucleus Accumbens (NAc) is implicated in craving, reward and reinforcement of alcohol drinking. The NAc/Striatum expresses the highest levels of high affinity adenosine A2A receptors in the central nervous system (CNS) and is characterized by co-expression of A2A with dopamine D2 receptors (D2) on the same neurons. We have evidence that subthreshold concentrations of the D2 agonist NPA and ethanol, that have no effect alone, act synergistically when added together to stimulate PKA signaling. Synergy requires bettayamma, dimers and A2 receptors. Neurons that express D2 and A2 on the same cells, as in the NAc, are simultaneously hypersensitive to ethanol in the presence of dopaminergic tone and hypersensitive to D2 signaling in the presence of ethanol. Synergy may play a role in ethanol consumption. Expression of a beta/gamma, inhibitor in NAc reduces voluntary ethanol consumption. Our hypothesis is that unique and specific signaling components are responsible for synergy between D2 and ethanol/A2 in NAc/striatal neurons and that these molecules regulate drinking behaviors. The overall goal of this project is (a) to identify the specific molecular signaling components in NAc/Striatal neurons which regulate ethanol-induced increases in PKA signaling and reinforcement of ethanol consumption, and, (b) to develop new therapeutics for alcoholism. Our specific aims are: I: Identify specific G-protein components responsible for synergy between ethanol and NPA for activation of PKA signaling; Il: Test whether a specific activator of G protein signaling, AGS3, selectively regulates synergy between D2 and ethanol; III: Test which specific beta/gamma dimers released upon D2 activation activate adenylyl cyclase II and/or IV in primary striatal neurons; and IV: Test the role of the ethanol/A2 and D2 signaling components in ethanol operant self-administration and in CNS responses to ethanol. The experiments in this proposal will identify and validate novel targets for the development of new therapeutic agents to treat alcoholism and alcohol abuse.
描述(由申请人提供):伏核(NAc)与饮酒的渴望、奖励和强化有关。NAc/纹状体在中枢神经系统(CNS)中表达最高水平的高亲和力腺苷A2 A受体,并且特征在于A2 A与多巴胺D2受体(D2)在相同神经元上的共表达。我们有证据表明,阈下浓度的D2激动剂NPA和乙醇,单独没有效果,协同作用时,加在一起刺激PKA信号。协同作用需要bettayamma,二聚体和A2受体。在同一细胞上表达D2和A2的神经元(如NAc中)在多巴胺能紧张的情况下同时对乙醇过敏,在乙醇的情况下对D2信号传导过敏。协同效应可能在乙醇消费中发挥作用。β/γ抑制剂在NAc中的表达减少了自愿的乙醇消耗。我们的假设是,独特的和特定的信号成分是负责D2和乙醇/A2之间的协同作用,在NAc/纹状体神经元,这些分子调节饮酒行为。该项目的总体目标是(a)鉴定NAc/纹状体神经元中调节乙醇诱导的PKA信号传导增加和乙醇消耗增强的特定分子信号传导组分,和(B)开发新的酒精中毒治疗剂。 我们的具体目标是:我:Il:测试G蛋白信号传导的特异性激活剂AGS 3是否选择性地调节D2和乙醇之间的协同作用; III:测试在D2激活时释放的哪些特异性β/γ二聚体激活初级纹状体神经元中的腺苷酸环化酶II和/或IV;以及IV:测试乙醇/A2和D2信号传导组分在乙醇操作性自我给药和中枢神经系统对乙醇的反应中的作用。该提案中的实验将确定和验证用于开发治疗酒精中毒和酒精滥用的新治疗药物的新靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ivan Diamond其他文献

Ivan Diamond的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ivan Diamond', 18)}}的其他基金

Ethanol regulation of signaling: from cells to behavior
乙醇对信号传导的调节:从细胞到行为
  • 批准号:
    7125953
  • 财政年份:
    2005
  • 资助金额:
    $ 49.18万
  • 项目类别:
Ethanol regulation of signaling: from cells to behavior
乙醇对信号传导的调节:从细胞到行为
  • 批准号:
    6871580
  • 财政年份:
    2005
  • 资助金额:
    $ 49.18万
  • 项目类别:
Ethanol regulation of signaling: from cells to behavior
乙醇对信号传导的调节:从细胞到行为
  • 批准号:
    7286727
  • 财政年份:
    2005
  • 资助金额:
    $ 49.18万
  • 项目类别:
Ethanol regulation of signaling: from cells to behavior
乙醇对信号传导的调节:从细胞到行为
  • 批准号:
    7630600
  • 财政年份:
    2005
  • 资助金额:
    $ 49.18万
  • 项目类别:
MEMBRANE DISORDERS IN ALCOHOLISM
酗酒中的膜疾病
  • 批准号:
    6246562
  • 财政年份:
    1997
  • 资助金额:
    $ 49.18万
  • 项目类别:
MOLECULAR NEUROSCIENCE AND GENETICS OF ALCOHOLISM
酗酒的分子神经科学和遗传学
  • 批准号:
    2000218
  • 财政年份:
    1997
  • 资助金额:
    $ 49.18万
  • 项目类别:
MOLECULAR NEUROSCIENCE AND GENETICS OF ALCOHOLISM
酗酒的分子神经科学和遗传学
  • 批准号:
    2633271
  • 财政年份:
    1997
  • 资助金额:
    $ 49.18万
  • 项目类别:
MOLECULAR NEUROSCIENCE AND GENETICS OF ALCOHOLISM
酗酒的分子神经科学和遗传学
  • 批准号:
    2855761
  • 财政年份:
    1997
  • 资助金额:
    $ 49.18万
  • 项目类别:
MOLECULAR NEUROSCIENCE AND GENETICS OF ALCOHOLISM
酗酒的分子神经科学和遗传学
  • 批准号:
    6341468
  • 财政年份:
    1997
  • 资助金额:
    $ 49.18万
  • 项目类别:

相似海外基金

Mechanism of allosteric action of extracellular ATP at the adenosine A2a receptor
细胞外 ATP 对腺苷 A2a 受体的变构作用机制
  • 批准号:
    570072-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Targeting the Host Adenosine A2A Receptor to Protect Against Fatal Rickettsiosis Using an Approved Parkinson's Disease Drug
使用经批准的帕金森病药物靶向宿主腺苷 A2A 受体来预防致命的立克次体病
  • 批准号:
    9510124
  • 财政年份:
    2018
  • 资助金额:
    $ 49.18万
  • 项目类别:
Structure and Dynamics of Adenosine A2A receptor - Gs Complexes
腺苷 A2A 受体 - Gs 复合物的结构和动力学
  • 批准号:
    382662
  • 财政年份:
    2018
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Operating Grants
Understanding the Allosteric Regulation of Adenosine A2A Receptor by Metal Cations
了解金属阳离子对腺苷 A2A 受体的变构调节
  • 批准号:
    515106-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
靶向肺癌患者的腺苷 A2A 受体免疫检查点
  • 批准号:
    9175600
  • 财政年份:
    2016
  • 资助金额:
    $ 49.18万
  • 项目类别:
Molecular imaging of adenosine A2A receptor: a first-in-human study
腺苷 A2A 受体的分子成像:首次人体研究
  • 批准号:
    16H05396
  • 财政年份:
    2016
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Anti-inflammatory activities of the adenosine A2A receptor in human neutrophils: delineation of resolution and anti-ageing pathways
人中性粒细胞中腺苷 A2A 受体的抗炎活性:解析和抗衰老途径的描述
  • 批准号:
    351807
  • 财政年份:
    2016
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Operating Grants
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
靶向肺癌患者的腺苷 A2A 受体免疫检查点
  • 批准号:
    9462266
  • 财政年份:
    2016
  • 资助金额:
    $ 49.18万
  • 项目类别:
Effects of Adenosine A2a receptor deficiency on a-synuclein-induced neurotoxicity
腺苷 A2a 受体缺陷对 a-突触核蛋白诱导的神经毒性的影响
  • 批准号:
    15K09308
  • 财政年份:
    2015
  • 资助金额:
    $ 49.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Adenosine A2A receptor cross-activation of TrkB in Huntington's disease
亨廷顿病中 TrkB 的腺苷 A2A 受体交叉激活
  • 批准号:
    8104912
  • 财政年份:
    2011
  • 资助金额:
    $ 49.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了